Sagittarius Life Science Corp (3205.TWO)
TWD 27.55
(-9.97%)
TWD 27.55
(-9.97%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -55.03 Million TWD | 25.82% |
| 2022 | -74.2 Million TWD | 14.14% |
| 2021 | -86.42 Million TWD | -16.6% |
| 2020 | -74.11 Million TWD | 37.98% |
| 2019 | -119.51 Million TWD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -9.34 Million TWD | 49.77% |
| 2024 Q2 | -16.37 Million TWD | -75.21% |
| 2023 Q3 | -10.94 Million TWD | 4.76% |
| 2023 Q2 | -11.48 Million TWD | 17.97% |
| 2023 Q4 | -18.6 Million TWD | -70.06% |
| 2023 FY | -55.03 Million TWD | 25.82% |
| 2023 Q1 | -14 Million TWD | 24.31% |
| 2022 Q4 | -18.5 Million TWD | 0.0% |
| 2022 FY | -74.2 Million TWD | 14.14% |
| 2021 FY | -86.42 Million TWD | -16.6% |
| 2020 FY | -74.11 Million TWD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -51.78 Million TWD | -6.29% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 251.01 Million TWD | 121.927% |
| Level Biotechnology Inc. | 62.9 Million TWD | 187.495% |
| NeoCore Technology Co., Ltd. | -64.64 Million TWD | 14.86% |
| TaiMed Biologics Inc. | -194.81 Million TWD | 71.747% |
| GlycoNex Incorporation | -178.36 Million TWD | 69.142% |
| VBI | -6.6 Million TWD | -733.798% |
| GeneReach Biotechnology Corp. | -166.27 Million TWD | 66.898% |
| Taiwan Advance Bio-Pharmaceutical Inc. | -10.68 Million TWD | -415.25% |
| SynCore Biotechnology Co.,Ltd | -38.17 Million TWD | -44.187% |
| Genomics BioSci & Tech. Co.,Ltd. | -168.06 Million TWD | 67.252% |
| Visgeneer Inc. | -19.58 Million TWD | -180.969% |
| Mycenax Biotech Inc. | -682.84 Million TWD | 91.94% |
| Sunmax Biotechnology Co., Ltd. | 625.7 Million TWD | 108.796% |
| G&E Herbal Biotechnology Co., Ltd. | 72.4 Million TWD | 176.021% |
| Neith Corporation | -40.03 Million TWD | -37.484% |
| Medigen Vaccine Biologics Corporation | -1.15 Billion TWD | 95.255% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -6.04 Million TWD | -810.187% |
| Enimmune corporation | -223.74 Million TWD | 75.401% |
| TaiRx, Inc. | -212.29 Million TWD | 74.074% |
| CHO Pharma, Inc. | -306.08 Million TWD | 82.019% |
| EirGenix Inc. | -915.2 Million TWD | 93.986% |
| BioLASCO Taiwan Co., Ltd. | 49.74 Million TWD | 210.647% |
| Sunny Pharmtech Inc. | -63.32 Million TWD | 13.078% |
| Lin BioScience, Inc. | -687.19 Million TWD | 91.991% |
| BioGend Therapeutics Co., Ltd. | -156.32 Million TWD | 64.792% |
| Feng Chi Biotech Corp. | 22.79 Million TWD | 341.484% |
| Bio Preventive Medicine Corp. | -73.28 Million TWD | 24.897% |
| Lukas Biomedical Inc. | -47.35 Million TWD | -16.231% |
| RBC Bioscience Corporation | 6.43 Million TWD | 955.972% |
| BiOptic Inc. | 37.74 Million TWD | 245.81% |
| BRIM Biotechnology, Inc. | -688.02 Million TWD | 92.0% |
| Shine-On BioMedical Co.,Ltd. | -37.16 Million TWD | -48.094% |
| Great Novel Therapeutics Biotech & Medicals | -61.54 Million TWD | 10.564% |
| Syngen Biotech Co.,Ltd. | 274.82 Million TWD | 120.027% |
| Advagene Biopharma Co., Ltd. | -92.11 Million TWD | 40.246% |
| NaviFUS Corp. | -65.72 Million TWD | 16.264% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -88.08 Million TWD | 37.519% |
| Sinew Pharma Inc. | -170.92 Million TWD | 67.799% |
| Andros Pharmaceuticals Co.,Ltd | -68.15 Million TWD | 19.249% |
| Greenyn Biotechnology Co., Ltd | 130.66 Million TWD | 142.123% |
| Lumosa Therapeutics Co., Ltd. | -238.04 Million TWD | 76.878% |
| AP Biosciences Inc | -339.29 Million TWD | 83.778% |
| Medigen Biotechnology Corp. | -561.29 Million TWD | 90.194% |
| 3D Global Biotech Inc. | -57.95 Million TWD | 5.025% |
| Pharmosa Biopharm Inc. | 8.45 Million TWD | 750.887% |
| Intech Biopharm Corporation | -337.98 Million TWD | 83.716% |
| Oneness Biotech Co., Ltd. | -1.31 Billion TWD | 95.808% |
| Eusol Biotech Co.,Ltd. | -51.61 Million TWD | -6.638% |
| TWi Biotechnology, Inc. | -170.68 Million TWD | 67.754% |
| Ever Supreme Bio Technology Co., Ltd | 539.39 Million TWD | 110.204% |
| TCI GENE Inc. | 11.67 Million TWD | 571.507% |
| MegaPro Biomedical Co., Ltd | -127.54 Million TWD | 56.848% |
| Senhwa Biosciences, Inc. | -296.3 Million TWD | 81.425% |
| Taiwan Bio Therapeutics Co., Ltd | -217.51 Million TWD | 74.696% |
| NatureWise Biotech & Medicals Corporation | 10.12 Million TWD | 643.864% |
| PharmaEngine, Inc. | 274.65 Million TWD | 120.04% |
| Savior Lifetec Corporation | 30.03 Million TWD | 283.28% |
| TaiGen Biopharmaceuticals Holdings Limited | 136.73 Million TWD | 140.253% |
| OBI Pharma, Inc. | -1.04 Billion TWD | 94.741% |
| Meribank Biotech Co., Ltd | -125.34 Million TWD | 56.09% |
| Acepodia, Inc. | -817.31 Million TWD | 93.266% |
| Caliway Biopharmaceuticals Co., Ltd. | -488.45 Million TWD | 88.732% |